Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures
March 11th, 2010 · No Comments
FDA review of available data have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
Tags: FDA · FDA Alerts
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.